146 related articles for article (PubMed ID: 33217066)
1. The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis.
Guimarães LM; Diniz MG; Rogatto SR; Gomez RS; Gomes CC
J Oral Pathol Med; 2021 Aug; 50(7):632-638. PubMed ID: 33217066
[TBL] [Abstract][Full Text] [Related]
2. Association between histopathological features of dysplasia in oral leukoplakia and loss of heterozygosity.
Fonseca-Silva T; Diniz MG; de Sousa SF; Gomez RS; Gomes CC
Histopathology; 2016 Feb; 68(3):456-60. PubMed ID: 26042642
[TBL] [Abstract][Full Text] [Related]
3. Predictors of malignant transformation in oral leukoplakia and proliferative verrucous leukoplakia: An observational prospective study including the DNA ploidy status.
Pentenero M; Castagnola P; Castillo FV; Isaevska E; Sutera S; Gandolfo S
Head Neck; 2023 Oct; 45(10):2589-2604. PubMed ID: 37563936
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
[TBL] [Abstract][Full Text] [Related]
5. Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.
Li X; Liu L; Zhang J; Ma M; Sun L; Li X; Zhang H; Wang J; Huang Y; Li T
Sci China Life Sci; 2021 Sep; 64(9):1379-1391. PubMed ID: 34351567
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
Thomas G; Tr S; George S P; Somanathan T; Sarojam S; Krishnankutti N; Sreedharan H; Ankathil R
Asian Pac J Cancer Prev; 2020 Feb; 21(2):309-316. PubMed ID: 32102504
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
8. Correlation between dysplasia and ploidy status in oral leukoplakia.
van Zyl AW; van Heerden MB; Langenegger E; van Heerden WF
Head Neck Pathol; 2012 Sep; 6(3):322-7. PubMed ID: 22430773
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia and DNA ploidy to prognosticate clinical outcome in oral potentially malignant disorders.
Sathasivam HP; Nayar D; Sloan P; Thomson PJ; Odell EW; Robinson M
J Oral Pathol Med; 2021 Feb; 50(2):200-209. PubMed ID: 33151583
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy in proliferative verrucous leukoplakia.
Klanrit P; Sperandio M; Brown AL; Shirlaw PJ; Challacombe SJ; Morgan PR; Odell EW
Oral Oncol; 2007 Mar; 43(3):310-6. PubMed ID: 16931117
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intra-lesional molecular heterogeneity of oral leukoplakia.
Gomes CC; Fonseca-Silva T; Galvão CF; Friedman E; De Marco L; Gomez RS
Oral Oncol; 2015 Feb; 51(2):178-81. PubMed ID: 25467776
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa.
Odell EW
Oral Dis; 2021 Nov; 27(8):1993-2007. PubMed ID: 33577101
[TBL] [Abstract][Full Text] [Related]
13. S-phase fraction and DNA ploidy in oral leukoplakia.
Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
[TBL] [Abstract][Full Text] [Related]
14. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
[TBL] [Abstract][Full Text] [Related]
15. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
16. DNA content as a prognostic marker in patients with oral leukoplakia.
Sudbø J; Kildal W; Risberg B; Koppang HS; Danielsen HE; Reith A
N Engl J Med; 2001 Apr; 344(17):1270-8. PubMed ID: 11320386
[TBL] [Abstract][Full Text] [Related]
17. Molecular screening of oral precancer.
Graveland AP; Bremmer JF; de Maaker M; Brink A; Cobussen P; Zwart M; Braakhuis BJ; Bloemena E; van der Waal I; Leemans CR; Brakenhoff RH
Oral Oncol; 2013 Dec; 49(12):1129-35. PubMed ID: 24120275
[TBL] [Abstract][Full Text] [Related]
18. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
19. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia.
Sudbø J; Bryne M; Johannessen AC; Kildal W; Danielsen HE; Reith A
J Pathol; 2001 Jul; 194(3):303-10. PubMed ID: 11439362
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of DNA ploidy status in patients with oral leukoplakia.
Bremmer JF; Brakenhoff RH; Broeckaert MA; Beliën JA; Leemans CR; Bloemena E; van der Waal I; Braakhuis BJ
Oral Oncol; 2011 Oct; 47(10):956-60. PubMed ID: 21880540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]